Navigation Links
Lilly Oncology To Disclose New Pipeline Data At ASCO 2012
Date:5/14/2012

00 AM - 12:00 PM
  • A randomized, multicenter, double-blind, placebo (PBO)-controlled phase III study of paclitaxel (PTX) with or without ramucirumab (IMC-1121B; RAM) in patients (pts) with metastatic gastric adenocarcinoma, refractory to or progressive after first-line therapy with platinum (PLT) and fluoropyrimidine (FP).
  • Author/Speaker: Hansjochen Wilke
  • Location: S Hall A2; Poster Board 53B
  • Abstract #TPS4146: Trials in Progress Poster Session: Monday, June 4, 2012, 8:00 AM - 12:00 PM
    • A multicenter, randomized, double-blind, phase III study of ramucirumab (IMC-1121B; RAM) and best supportive care (BSC) versus placebo (PBO) and BSC as second-line treatment in patients (pts) with hepatocellular carcinoma (HCC) following first-line therapy with sorafenib (SOR).
    • Author/Speaker: Andrew X. Zhu
    • Location: S Hall A2; Poster Board 54A

NOTCH inhibitor (LY900009)

  • Abstract #3008: Oral Abstract Session: Sunday, June 3, 2012, 12:15 PM - 12:30 PM
    • A first-in-human phase I study of the oral Notch inhibitor LY900009 in patients with advanced cancer
    • Author/Speaker: Shubham Pant
    • Location: E Arie Crown Theater

p38 MAPK inhibitor (LY2228820 dimesylate)

  • Abstract # 3001: Oral Abstract Session: Sunday, June 3, 2012, 10:00 AM – 10:15 AM
    • A first-in-human phase I study of the oral p38 MAPK inhibitor LY2228820 dimesylate in patients with advanced cancer.
    • Author/Speaker: Matthew P. Goetz
    • Location: E Arie Crown Theater

P70S6K/AKT inhibitor (LY2780301)

  • Abstract # 3005: Oral Abstract
    '/>"/>

SOURCE Eli Lilly and Company
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Lilly Applauds Law Enforcement Officials for their Successful Investigation and Recovery of Pharmaceuticals Stolen from Connecticut Distribution Center
2. Lilly Sets Date for Lilly Diabetes Pipeline Update to the Investment Community
3. Zacks Industry Outlook Highlights: Eli Lilly, Forest Labs, ViroPharma, Novartis and United Therapeutics
4. DiversityInc Names Lilly a Top Company for Diversity
5. Lilly Declares Second-Quarter 2012 Dividend
6. Lilly Diabetes and Walgreens Launch Diabetes Hypoglycemia Awareness Campaign
7. Lillys John Lechleiter Becomes PhRMA Board Chairman; Robert J. Hugin, Ian Read Assume New Posts
8. Lilly Confirms Date and Conference Call for First-Quarter 2012 Financial Results Announcement
9. Lilly Diabetes supports Diabetes Scholars Foundation with $100,000 donation in 2012
10. Fifth Lilly Oncology on Canvas Art Competition Invites All Touched by Cancer to Share Their Cancer Journeys
11. Boehringer Ingelheim and Lillys new oral type 2 diabetes treatment for adults, Jentadueto™ (linagliptin/metformin hydrochloride) tablets, now available in U.S. pharmacies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/23/2015)... , Jan. 23, 2015 For the pharmaceutical industry, marketplace ... with payers. Likewise, the importance of the managed markets function ... continue to grow as payer formularies and provider networks play ... At the same time, managed markets leaders must continually ...
(Date:1/23/2015)... Jan. 23, 2015  The Partnership to Fight Chronic Disease (PFCD) released ... care leaders and a new study analyzing the impact of increased ... a nationwide coalition working to educate policy makers and the public ... Capitol was focused on how the Iowa ...
(Date:1/23/2015)... DUBLIN , Jan. 23, 2015  Immune Therapeutics, Inc. today ... Inc. for the compounding, packaging and distributing of its naltrexone ... the United States . KRS ... compounding naltrexone tablets in various strengths for individual patients in ...
Breaking Medicine Technology:As Payer Influence Rises, Pharmaceutical Companies work to Optimize the Managed Markets Function 2New research shows Iowa health exchange would benefit from improvements 2New research shows Iowa health exchange would benefit from improvements 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 2Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 3Immune Therapeutics, Inc. Announces Agreement with KRS Global Biotechnology, Inc. 4
... (NASDAQ: DCTH ) today announced the Therapeutic ... approved the Delcath Hepatic CHEMOSAT® Delivery system for listing ... TGA,s approval allows Delcath to market and sell the ... Australia represents another achievement for Delcath as we seek ...
... Feb. 14, 2012  Intellect Neurosciences, Inc. (OTCBB: ILNS), ... development of disease-modifying therapeutic agents for the treatment ... that it submitted a statement setting out its ... preliminary decision to revoke the company,s ANTISENILIN® patents ...
Cached Medicine Technology:Delcath Receives Regulatory Approval to Commercialize Hepatic CHEMOSAT® Delivery System in Australia 2Delcath Receives Regulatory Approval to Commercialize Hepatic CHEMOSAT® Delivery System in Australia 3Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings 2Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings 3Intellect Neurosciences Submits Statement Setting Grounds for Appeal in European Patent Proceedings 4
(Date:1/22/2015)... Recently, Weddingshe.com has added many trendy Champagne wedding ... revenues in the past three years. Today, the business announces ... According to the sales manager of the company, this is ... 2015. This point can be reflected on the discounted wedding ...
(Date:1/22/2015)... 2015 Payday lending practices in four ... cause financial distress to the states that permit them, ... University’s Center on Race and Wealth. , While they ... payday loans at the same time substantially depress economic ...
(Date:1/22/2015)... JJsHouse.com is a famous dress online store for wedding dresses ... latest collection of wedding dresses , and launches a site-wide ... wedding dress on your big day; the wedding gown is ... wants to find the most suitable wedding dress. Now, we ...
(Date:1/22/2015)... Richmond, VA (PRWEB) January 22, 2015 ... the power at the Science Museum of Virginia. Wicked ... 24. , Wicked Plants unearths 75 poisonous, carnivorous and ... traverse through each room to uncover the biochemical, physical ...
(Date:12/26/2014)... 26, 2014 It is said that nothing ... Today, UWDress.com, the famous wedding dress supplier, shows its ... site-wide cocktail gown promotion. , UWDress.com’s navy cocktail gowns ... they come in high fashion styles. Simple dresses in bright ...
Breaking Medicine News(10 mins):Health News:Weddingshe Announces A Special Offer On Its Popular Glamorous Wedding Dresses 2Health News:Howard University Spotlights the Economic Impact of Payday Lending in Southern States 2Health News:Find The Most Suitable Wedding Dress At JJsHouse.com 2Health News:Wicked Plants are taking over the Science Museum of Virginia 2Health News:UWDress.com Shows Its New Navy Cocktail Dresses For 2015 2
... improvements and less cell degeneration , , SUNDAY, Feb. ... appears able to slow or stop Alzheimer,s disease in ... The brain,s entorhinal cortex, which supports memory, normally produces ... decrease when Alzheimer,s is present. When researchers injected BDNF ...
... Trust for America,s Health released the following statement after ... cut more than $100 billion from the American Recovery ... the Senate struck a final bargain to strip all ... plan, failing to recognize that this funding would have ...
... pain and swelling , , FRIDAY, Feb. 6 (HealthDay News) ... symptoms in people with rheumatoid arthritis (RA) has been ... study included two postmenopausal women with advanced RA. Researchers ... women,s affected joints. IL-1Ra protein blocks the actions of ...
... Aflac Incorporated,announced today that it is providing expanded detail ... The company has elevated additional ... and Tier 1 perpetual debenture, including CUSIP numbers for ... The company has also,prepared and elevated a frequently asked ...
... Supplies tend to run dangerously short this time of year , , ... gone, and everyone has settled back into regular routines. , But ... this time of the year. , The nation,s blood supply tends ... to a decline in donations. Now that the new year is ...
... with low glycemic index sweeteners and berries to produce a new type ... benefits of berry antioxidants and probiotics are also discussed with comments from ... ... long been regarded as a sweet and sinful indulgence. Everyone knows ...
Cached Medicine News:Health News:Brain Protein May Have Potential Against Alzheimer's 2Health News:Gene Therapy May Ease Rheumatoid Arthritis 2Health News:Aflac Incorporated Provides Added Detail on Perpetual Debenture Holdings 2Health News:Needed: Blood Donations 2Health News:Needed: Blood Donations 3Health News:Losing Weight with Chocolate on Valentine's Day 2
... Choice for Urinary Tract Infection ... Line. A multi-center study was ... potential UTIs. There were 1,887 ... leukocyte and nitrite results of ...
... busy physician's office environment, interruptions ... to timing errors and variability ... are read visually. Studies have ... performed with an instrument, sensitivity ...
Keep your laboratory efficient. And meet your volume needs. When you set the pace with the Clinitek 500 Urine Chemistry Analyzer. Its ready when you are. No warm-up. No calibration. No bells. Just pr...
... These dual pressure sensor ... sampling/slow-speed injection, slow-speed injection/guide wire, ... model SPC-784A for high-speed injection ... side openings and an open-end ...
Medicine Products: